A fatal case of multiple brain hemorrhages associated with lecanemab
Today the FDA granted accelerated approval of the anti-amyloid monoclonal antibody lecanemab, now going by the trade name Leqembi. I have mixed feelings about this. Lecanemab is the only disease-modifying drug so far to...
Recent Comments